Personalized Treatments for Depressive Symptoms in Patients With Advanced Heart Failure

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 494 participants.

Also called NCT03688100

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 494 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03688100
Other papers using this trial's data
  • Comparative Effectiveness of Psychotherapy vs Antidepressants for Depression in Heart Failure: A Randomized Clinical Trial JAMA network open, 2024-01-02 DOI, PubMed 38231511, PMC10794938 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03688100. Randomized; no masking; primary purpose treatment. Start 2018-11-09 (actual); primary completion 2021-10-25 (actual). Results posted on 2024-03-19.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Personalized Treatments for Depressive Symptoms in Patients With Advanced Heart Failure
Condition
Depression
Condition
Heart Failure
Intervention (Behavioral)
Behavioral Activation Therapy
Intervention (Drug)
Medication Management
Lead sponsor
Cedars-Sinai Medical Center (class: other)
Collaborator
Patient-Centered Outcomes Research Institute (class: other)

Record details

Record id
cardio:ct-nct03688100
Content hash
3c8925e7d13779451223af1b6db7da894d964e87e07a62df62ac0181ccc33eed